Hostname: page-component-74656f9884-j7cmm Total loading time: 0 Render date: 2026-11-07T03:38:58.709Z Has data issue: false hasContentIssue false

Gelatin-based hydrogels for biomedical applications

Published online by Cambridge University Press:  03 October 2017

Panupong Jaipan
Affiliation:
Department of Material Science & Engineering, North Carolina State University, Box 7907, Raleigh, NC 27695, USA
Alexander Nguyen
Affiliation:
Joint Department of Biomedical Engineering, University of North Carolina and North Carolina State University, Box 7115, Raleigh, NC 27695, USA
Roger J. Narayan*
Affiliation:
Department of Material Science & Engineering, North Carolina State University, Box 7907, Raleigh, NC 27695, USA Joint Department of Biomedical Engineering, University of North Carolina and North Carolina State University, Box 7115, Raleigh, NC 27695, USA
*
Address all correspondence to Roger J. Narayan at roger_narayan@msn.com

Abstract

Gelatin-based hydrogels derived from hydrolysis of collagen have been extensively used in pharmaceutical and medical applications because of their biocompatibility and biodegradability. For example, gelatin-based hydrogels are finding use in drug delivery and tissue engineering because they are able to promote cell adhesion and proliferation. In addition, these hydrogels can be used as wound dressings due to their attractive fluid absorbance properties. Manufacturing technologies such as ultraviolet stereolithography and two-photon polymerization can be used to prepare structures containing photosensitive gelatin-based hydrogels. This review describes the preparation of gelatin-based hydrogels and use of these materials for biomedical applications.

Information

Type
Biomaterials for 3D Cell Biology Prospective Articles
Copyright
Copyright © Materials Research Society 2017 
Figure 0

Figure 1. Schematic representation of two-photon polymerization (2PP) setup; reprinted with permission from Ref. 28. Copyright (2011) American Chemical Society.

Figure 1

Figure 2. The structure of 3D plotted composite scaffolds of pure alginate (a, d, and g); the structure of 3D plotted composite scaffolds of gelatin/alginate with a mass ratio of 54/46 (b, e, and h); and the structure of 3D-plotted scaffolds of gelatin/alginate/hydroxyapatite with a mass ratio of 39/30/31 (c, f, and i). Note that A–C are microscopic images with scale bar = 1 mm; (d–f) are SEM images of the surface with scale bar = 20 µm; and (g–i) are SEM images of rods cross-sections with scale bar = 20 µm; reproduced from, Ref. 51. Copyright (2015), with permission of The Royal Society of Chemistry.

Figure 2

Figure 3. Confocal laser scanning microscopy images of human bone marrow-derived mesenchymal stem cells seeded on (a) and (b) 3D-plotted gelatin/alginate/hydroxyapatite scaffold with a mass ratio of 39/30/31; (c) and (d) gelatin/alginate with a mass ratio of (54/46); (e) alginate scaffolds; (a, c, e) scaffolds on day 1 and (b and d) scaffolds on day 21 with scale bar = 100 µm; reproduced from, Ref. 51. Copyright (2015), with permission of The Royal Society of Chemistry.

Figure 3

Figure 4. Schematic representation for synthesis of the (β-CD)-crosslinked gelatin-based hydrogel for anticancer drug MTX loading; reproduced from Ref. 56. Copyright (2013), with permission of The Royal Society of Chemistry.

Figure 4

Figure 5. Gelatin-based hydrogel scaffold seeded with porcine mesenchymal stem cells (MSCs) after 11 days: (a) phase contrast image; (b–e) blue and green stain fluorescence images indicating cell distributions; (f, g) magnified view locating the deposition of calcium phosphate; and (h) the energy dispersive x-ray spectrum confirming the presence of calcium and phosphate on the 2PP-generated scaffold; reprinted with permission from Ref. 28. Copyright (2011) American Chemical Society.

Figure 5

Figure 6. The top images illustrating morphological appearance of MSCs and the bottom representing the viable MSCs after 9 days culture seeded on G13_LNO5, and Hoechst 33258 (blue) has been used for clarifying viable MSC nuclei; reprinted from Ref. 10. Copyright (2012), with permission from John Wiley & Sons, Inc.

Figure 6

Figure 7. Images illustrating the appearance of (a) the wound excised on the rat model; (b) gel applied on wound; (c) control wounds at 5, (e) 10, (g) 15 days, respectively; (d) test wounds at 5 days, (f) 10 days, and (h) 15 days; reprinted from. Ref. 74. Copyright (2005), with permission from Elsevier.